Reduction in life expectancy in Brazil after COVID-19
- PMID: 34188224
- PMCID: PMC8446334
- DOI: 10.1038/s41591-021-01437-z
Reduction in life expectancy in Brazil after COVID-19
Abstract
Brazil has been heavily affected by coronavirus disease 2019 (COVID-19). In this study, we used data on reported total deaths in 2020 and in January-April 2021 to measure and compare the death toll across states. We estimate a decline in 2020 life expectancy at birth (e0) of 1.3 years, a mortality level not seen since 2014. The reduction in life expectancy at age 65 (e65) in 2020 was 0.9 years, setting Brazil back to 2012 levels. The decline was larger for males, widening by 9.1% the female-male gap in e0. Among states, Amazonas lost 60.4% of the improvements in e0 since 2000. In the first 4 months of 2021, COVID-19 deaths represented 107% of the total 2020 figures. Assuming that death rates would have been equal to 2019 all-cause rates in the absence of COVID-19, COVID-19 deaths in 2021 have already reduced e0 in 2021 by 1.8 years, which is slightly larger than the reduction estimated for 2020 under similar assumptions.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.
Conflict of interest statement
Competing interests
The authors declare no competing interests.
Figures




References
-
- Marinho F, et al.Excess Mortality in Brazil: A Detailed Description of Trends in Mortality During the COVID-19 Pandemic. in Technical Note. Vital Strategies. (Vital Strategies. https://www.vitalstrategies.org/resources/excess-mortality-in-brazil-a-d..., 2020).
-
- Nuzzo JB, Bell JA & Cameron EE Suboptimal US Response to COVID-19 Despite Robust Capabilities and Resources. JAMA 324, 1391–1392 (2020). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous